Cover Image

Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease

BackgroundAlthough type 2 diabetes mellitus (T2DM) plays a significant role in the association between metabolic dysfunction-associated fatty liver disease (MAFLD) and chronic kidney disease (CKD), how T2DM development and glycemic deterioration affect CKD and its renal function indicators, estimate...

Full description

Saved in:

Bibliographic Details
Main Authors:	Weitao Su (Author), Minhui Chen (Author), Ling Xiao (Author), Shanshan Du (Author), Lihua Xue (Author), Ruimei Feng (Author), Weimin Ye (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Metabolic dysfunction-associated fatty liver disease/metabolic dysfunction-associated steatotic liver disease: general provisions
by: O.E. Abaturov, et al.
Published: (2024)

Genetic predisposition to metabolic dysfunction-associated fatty liver disease
by: O.E. Abaturov, et al.
Published: (2024)

Behavioral deviations: healthcare-seeking behavior of chronic disease patients with intention to visit primary health care institutions
by: Shiyin Wu, et al.
Published: (2023)

Associations of an overall healthy lifestyle with the risk of metabolic dysfunction-associated fatty liver disease
by: Caimei Yuan, et al.
Published: (2024)

Aberrant DNA methylation associated with the development of metabolic dysfunction-associated fatty liver disease
by: O.E. Abaturov, et al.
Published: (2024)

Metabolic-associated fatty liver disease and lipoprotein metabolism
by: Joerg Heeren, et al.
Published: (2021)

Impact of anthropometric parameters on outcomes in Asians with metabolic dysfunction‐associated fatty liver disease
by: Kyu Yeon Choi, et al.
Published: (2023)

Dietary patterns and metabolic dysfunction-associated fatty liver disease in China's multi-ethnic regions
by: Xingren Zhu, et al.
Published: (2023)

The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review
by: Kiana Mohammadian, et al.
Published: (2024)

The Role of Metabolic Dysfunction-Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study
by: Suosu Wei, et al.
Published: (2023)

Metabolic-Associated Fatty Liver Disease: The Influence of Oxidative Stress, Inflammation, Mitochondrial Dysfunctions, and the Role of Polyphenols
by: Raissa Bulaty Tauil, et al.
Published: (2024)

Risk stratification using sarcopenia status among subjects with metabolic dysfunction‐associated fatty liver disease
by: Ho Soo Chun, et al.
Published: (2021)

Increased serum carboxylesterase-1 levels are associated with metabolic dysfunction associated steatotic liver disease and metabolic syndrome in children with obesity
by: Huanyu Wang, et al.
Published: (2024)

Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease
by: Marica Meroni, et al.
Published: (2020)

METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD) AND CARDIOMETABOLIC HEALTH EDUCATIONAL INITIATIVE WITH INTERNAL MEDICINE RESIDENTS
by: Jack Jnani, MD
Published: (2024)

Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Thyroid Function in Childhood Obesity: A Vicious Circle?
by: Valeria Calcaterra, et al.
Published: (2024)

The relationship between metabolic dysfunction‐associated fatty liver disease and low muscle mass in an asymptomatic Korean population
by: Ji Yeon Seo, et al.
Published: (2022)

Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed mice
by: Xiaoyong Xue, et al.
Published: (2024)

Knowledge of COVID-19 and its prevention among rural residents in Fuqing, China
by: Xiaojun Liu, et al.
Published: (2022)

Comparing diabetes prediction based on metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease: the ELSA-Brasil study
by: Gabriela Wünsch Lopes, et al.
Published: (2024)

Associations between body circumference and testosterone levels and risk of metabolic dysfunction-associated fatty liver disease: a mendelian randomization study
by: Lin Ning, et al.
Published: (2023)

Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003-2018
by: Zhilan Xie, et al.
Published: (2023)

Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Emidio Scarpellini, et al.
Published: (2024)

Association between dietary carbohydrate to fiber ratio and metabolic dysfunction associated fatty liver disease in adults: evidence from the NHANES 2017-2020
by: Zhenmin Liu, et al.
Published: (2024)

Hepatoprotective Effect of Bee Bread in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Rats: Impact on Oxidative Stress and Inflammation
by: Zaida Zakaria, et al.
Published: (2021)

Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway
by: Jinbiao He, et al.
Published: (2022)

New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease
by: Yu-Cheng Lin, et al.
Published: (2020)

Croton urucurana Baill. Ameliorates Metabolic Associated Fatty Liver Disease in Rats
by: Pablo Alvarez Auth, et al.
Published: (2022)

Clinical epidemiology of metabolic-associated fatty liver disease in overweight and obese children
by: O.O. Starets, et al.
Published: (2024)

Mechanisms of Action of Mesenchymal Stem Cells in Metabolic-Associated Fatty Liver Disease
by: Sitong Yi, et al.
Published: (2023)

Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders
by: Hui Deng, et al.
Published: (2020)

Iron, Oxidative Stress, and Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Sophie Gensluckner, et al.
Published: (2024)

Metabolically associated fatty liver disease - a disease of the 21st century: A review
by: Igor V. Maev, et al.
Published: (2022)

Associations of serum folate and vitamin C levels with metabolic dysfunction-associated fatty liver disease in US adults: A nationwide cross-sectional study
by: Yuqi Jiang, et al.
Published: (2022)

Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Children and Adolescents: Systematic Review and Meta-Analysis
by: Jiaye Liu, et al.
Published: (2021)

Corrigendum: Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway
by: Jinbiao He, et al.
Published: (2023)

Polyribonucleotide nucleotidyltransferase 1 participates in metabolic-associated fatty liver disease pathogenesis by affecting lipid metabolism and mitochondrial homeostasis
by: Canghai Guan, et al.
Published: (2024)

Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease
by: Cong xiang Shao, et al.
Published: (2021)

The state of vascular endothelium, clinical and metabolic features of patients with coronary heart disease combined with nonalcoholic fatty liver disease
by: N. S. Mykhailovska, et al.
Published: (2017)

Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH
by: Leigh Goedeke, et al.
Published: (2021)